Medicine ❯ Vaccines ❯ COVID-19 Vaccines ❯ mRNA Vaccines
The legal battle in London's High Court centers on Moderna’s claims of patent infringement by Pfizer and BioNTech, with significant implications for future mRNA technology applications.
